Cargando…

Hemopatch(®) as a Hemostatic Agent is Safe in Partial Nephrectomy: A Large, Single-Surgeon Retrospective Evaluation

INTRODUCTION: Partial nephrectomy (PN) has evolved into the surgical standard of care for localized renal lesions. Hemostatic agents (HA) support the surgeon in achieving local hemostasis during PN. We previously reported initial results with the HA Hemopatch(®) in PN. We now report our experiences...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hupe, Marie C., Büttner, Maximilian, Tabrizi, Pouriya Faraj, Merseburger, Axel S., Kuczyk, Markus A., Imkamp, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889526/ https://www.ncbi.nlm.nih.gov/pubmed/33277680 http://dx.doi.org/10.1007/s12325-020-01584-8

Ejemplares similares

Polyethylene glycol-coated collagen patch (hemopatch(®)) in open partial nephrectomy
por: Staehler, Michael, et al.
Publicado: (2021)

Is hemostatic agent effective and safe in minimally invasive partial nephrectomy?
por: Guo, Qiong, et al.
Publicado: (2022)

Control of bleeding in surgical procedures: critical appraisal of HEMOPATCH (Sealing Hemostat)
por: Lewis, Kevin Michael, et al.
Publicado: (2015)

The role of hemostatic agents in preventing complications in laparoscopic partial nephrectomy
por: Carrion, Diego M., et al.
Publicado: (2017)

Real-World Data on the Usage of Hemopatch® as a Hemostat and Dural Sealant in Cranial and Spinal Neurosurgery
por: Schebesch, Karl-Michael, et al.
Publicado: (2023)

Pilot study comparing the two hemostatic agents in patients undergoing partial nephrectomy
por: Palacios, Diego Aguilar, et al.
Publicado: (2013)

Hemopatch(®) is effective and safe to use: real-world data from a prospective European registry study
por: Lombardo, Carlo, et al.
Publicado: (2022)

Development of a clinical algorithm for treating urethral strictures based on a large retrospective single-center cohort
por: Tolkach, Yuri, et al.
Publicado: (2017)

Clinical Experience with Hemopatch® as a Dural Sealant in Cranial Neurosurgery
por: Schebesch, Karl-Michael, et al.
Publicado: (2019)

Robot-assisted partial nephrectomy is safe and effective for complex renal masses when performed by experienced surgeons
por: Juvet, Tristan S., et al.
Publicado: (2020)

Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Carcinoma
por: Faraj Tabrizi, Pouriya, et al.
Publicado: (2023)

A Hemostatic Technique in Robot-Assisted Laparoscopic Partial Nephrectomy and Its Impact on Renal Function
por: Raghavan, Deepak, et al.
Publicado: (2021)

Effectiveness of Hemopatch® versus Surgicel® Original to control mild and moderate liver bleeding
por: Uranues, Selman, et al.
Publicado: (2022)

Is robot-assisted partial nephrectomy safe for high complexity tumors?
por: Koukourikis, Periklis, et al.
Publicado: (2020)

A Single Surgeon's Experience with Open, Laparoscopic, and Robotic Partial Nephrectomy
por: Klaassen, Zachary, et al.
Publicado: (2014)

Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysis
por: Peters, Inga, et al.
Publicado: (2013)

Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy
por: Erne, Eva, et al.
Publicado: (2021)

Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients
por: Mazdak, Mehrdad, et al.
Publicado: (2021)

Impact of Surgical Experience Before Robot-assisted Partial Nephrectomy on Surgical Outcomes: A Multicenter Analysis of 2500 Patients
por: Harke, Nina N., et al.
Publicado: (2022)

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy
por: von Klot, Christoph A., et al.
Publicado: (2017)

Antioxidants as Renoprotective Agents for Ischemia during Partial Nephrectomy
por: Buys-Gonçalves, Gabriela F., et al.
Publicado: (2019)

‘Trifecta’ outcomes of robot-assisted partial nephrectomy: Results of the ‘low volume’ surgeon
por: Basatac, Cem, et al.
Publicado: (2020)

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
por: Katzendorn, Olga, et al.
Publicado: (2021)

Chitosan Hemostatic Dressing for Renal Parenchymal Wound Sealing in a Porcine Model: Implications for Laparoscopic Partial Nephrectomy Technique
por: Xie, Hua, et al.
Publicado: (2008)

DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma
por: Katzendorn, Olga, et al.
Publicado: (2021)

An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer
por: Merseburger, Axel S., et al.
Publicado: (2016)

Transition From Laparoscopic to Robotic Partial Nephrectomy: the Learning Curve for an Experienced Laparoscopic Surgeon
por: Lavery, Hugh J., et al.
Publicado: (2011)

Laparoscopic partial nephrectomy: A series of one hundred cases performed by the same surgeon
por: Campero, José M., et al.
Publicado: (2012)

ASO Author Reflection: Learning Curves in Robotic Partial Nephrectomy—Not Only the Surgeon Counts
por: Zeuschner, Philip, et al.
Publicado: (2020)

Editorial Commentary referring to: “Is robot-assisted partial nephrectomy safe for highly complexity tumors?”
por: Diana, Pietro, et al.
Publicado: (2020)

Laparoscopic retroperitoneoscopic nephrectomy and partial nephrectomy in children
por: Al-hazmi, Hamdan H., et al.
Publicado: (2015)

Multiplex Partial Nephrectomy, Repeat Partial Nephrectomy, and Salvage Partial Nephrectomy Remain the Primary Treatment in Multifocal and Hereditary Kidney Cancer
por: Baiocco, Joseph A., et al.
Publicado: (2017)

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Con
por: Kuusk, Teele, et al.
Publicado: (2022)

Staphylocoagulase as a hemostatic agent.
por: Mojovic, B., et al.
Publicado: (1969)

Hemopatch to Prevent Lymphatic Leak after Robotic Prostatectomy and Pelvic Lymph Node Dissection: A Randomized Controlled Trial
por: Teoh, Jeremy Yuen-Chun, et al.
Publicado: (2022)

Generation of Chimeric “ABS Nanohemostat” Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model
por: Huri, Emre, et al.
Publicado: (2013)

Mini-Flank Supra-12th Rib Incision for Open Partial Nephrectomy Compared with Laparoscopic Partial Nephrectomy and Traditional Open Partial Nephrectomy
por: Wang, Hang, et al.
Publicado: (2014)

Operative Outcomes of Robotic Partial Nephrectomy: A Comparison with Conventional Laparoscopic Partial Nephrectomy
por: Seo, Ill Young, et al.
Publicado: (2011)

Perioperative outcomes following robot-assisted partial nephrectomy for renal cell carcinoma according to surgeon generation
por: Toguchi, Makoto, et al.
Publicado: (2022)

Factors influencing warm ischemia time in robot-assisted partial nephrectomy change depending on the surgeon’s experience
por: Numakura, Kazuyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3fmr2d51v2jfnufc7t3kej4pim